Instrument Inactif

Autres langues PIRML ENT

Actions

PEL

INE140A01024

Autres langues

23/01	Piramal Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
30/10/25	Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding Its Payload-Linker Platform and Bioconjugate Capabilities
19/09/25	Piramal Enterprises Limited Announces Resignation of Upma Goel as Key Managerial Personnel, with Effect from September 30, 2025
19/09/25	Piramal Enterprises Limited Announces Resignation of Upma Goel as Chief Financial Officer, with Effect from September 30, 2025
10/09/25	India New Issue-Piramal Finance to issue near 3-year bonds, bankers say
29/07/25	Piramal Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
29/07/25	Piramal Enterprises' CFO Resigns; Vikash Singhla to Take Over Post-Merger
29/07/25	Piramal Enterprises June-quarter consol profit 2.76 billion rupees
21/07/25	Piramal Enterprises to consider fund raising
30/06/25	Piramal Enterprises Limited Approves Final Dividend for the Financial Year Ended March 31, 2025
06/06/25	Piramal Enterprises Gets Board Nod to Raise INR2.4 Billion Through Debenture Allotment
02/06/25	Piramal Enterprises Limited Appoints Jitendra Bhati as Chief Compliance Officer
28/05/25	Piramal Enterprises Limited announces Annual dividend, payable on July 30, 2025
27/05/25	Piramal Enterprises Limited Approves the Issuance of Secured, Rated, Listed, Redeemable, Non-Convertible Debentures
22/05/25	Piramal Enterprises To Consider Issuance Of NCDs
09/05/25	Indian Indices Extend Losses on Friday Amid Rising India-Pakistan Tensions
09/05/25	Piramal Enterprises Raises INR500 Million Via Debenture Issue
07/05/25	Piramal Enterprises : Announces Consolidated Results for Q4 and Full Year FY25
07/05/25	Piramal Enterprises' Fiscal Q4 Consolidated Profit Declines
06/05/25	Piramal Enterprises Sees Consol PAT 13-15 Billion Rupees For FY26
06/05/25	Piramal Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2025
06/05/25	Piramal Enterprises Limited Recommends Final Dividend for the Financial Year Ended 31 March, 2025
29/04/25	Piramal Enterprises Ltd - Approves Ncd Issuance Totaling 3 Billion Rupees
29/04/25	Piramal Enterprises : Alternatives Invests INR 160 Cr in Saimirra Innopharm Pvt. Ltd
24/04/25	Piramal Enterprises To Consider Issuance Of Non-Convertible Debentures